1. Home
  2. BNZI vs CDT Comparison

BNZI vs CDT Comparison

Compare BNZI & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • CDT
  • Stock Information
  • Founded
  • BNZI 2016
  • CDT 2019
  • Country
  • BNZI United States
  • CDT United States
  • Employees
  • BNZI N/A
  • CDT N/A
  • Industry
  • BNZI
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNZI
  • CDT Health Care
  • Exchange
  • BNZI Nasdaq
  • CDT Nasdaq
  • Market Cap
  • BNZI 9.5M
  • CDT 10.9M
  • IPO Year
  • BNZI N/A
  • CDT N/A
  • Fundamental
  • Price
  • BNZI $1.55
  • CDT $0.11
  • Analyst Decision
  • BNZI Strong Buy
  • CDT
  • Analyst Count
  • BNZI 1
  • CDT 0
  • Target Price
  • BNZI $125.00
  • CDT N/A
  • AVG Volume (30 Days)
  • BNZI 1.1M
  • CDT 34.8M
  • Earning Date
  • BNZI 11-14-2024
  • CDT 11-14-2024
  • Dividend Yield
  • BNZI N/A
  • CDT N/A
  • EPS Growth
  • BNZI N/A
  • CDT N/A
  • EPS
  • BNZI N/A
  • CDT N/A
  • Revenue
  • BNZI $4,310,782.00
  • CDT N/A
  • Revenue This Year
  • BNZI $23.28
  • CDT N/A
  • Revenue Next Year
  • BNZI $66.99
  • CDT N/A
  • P/E Ratio
  • BNZI N/A
  • CDT N/A
  • Revenue Growth
  • BNZI N/A
  • CDT N/A
  • 52 Week Low
  • BNZI $1.46
  • CDT $0.08
  • 52 Week High
  • BNZI $828.50
  • CDT $7.83
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 33.35
  • CDT 52.44
  • Support Level
  • BNZI $1.56
  • CDT $0.08
  • Resistance Level
  • BNZI $1.82
  • CDT $0.10
  • Average True Range (ATR)
  • BNZI 0.23
  • CDT 0.02
  • MACD
  • BNZI 0.02
  • CDT 0.00
  • Stochastic Oscillator
  • BNZI 8.65
  • CDT 33.24

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: